How do we get better at identifying patients with atrial fibrillation who are at 'truly low risk' or 'truly high risk' of stroke?

Review

Nadzeya Kuzniatsova et al. J Neurol Sci. 2010.

. 2010 Nov 15;298(1-2):21-2.

doi: 10.1016/j.jns.2010.08.015. Epub 2010 Sep 1.

No abstract available

Comment on

Stroke severity in concomitant cardiac sources of embolism in patients with atrial fibrillation.
Kim YD, Park B, Cha MJ, Nam CM, Nam HS, Ha JW, Chung N, Heo JH. Kim YD, et al. J Neurol Sci. 2010 Nov 15;298(1-2):23-7. doi: 10.1016/j.jns.2010.08.011. Epub 2010 Sep 15. J Neurol Sci. 2010. PMID: 20832823

Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice.
Lip GY. Lip GY. Thromb Haemost. 2010 Apr;103(4):683-5. doi: 10.1160/TH10-01-0038. Epub 2010 Feb 2. Thromb Haemost. 2010. PMID: 20135056 No abstract available.
Stroke prevention in atrial fibrillation--pharmacologic strategies.
Tiyyagura SR, Goldbarg SH, Mehta D. Tiyyagura SR, et al. Indian Heart J. 2007 Jul-Aug;59(4):311-5. Indian Heart J. 2007. PMID: 19126935 Review.
Reducing the risk for stroke in patients who have atrial fibrillation.
Garcia DA, Hylek E. Garcia DA, et al. Cardiol Clin. 2008 May;26(2):267-75, vii. doi: 10.1016/j.ccl.2007.12.011. Cardiol Clin. 2008. PMID: 18406999 Review.
Stroke prevention in atrial fibrillation patients.
Marinigh R, Lip GY, Lane DA. Marinigh R, et al. Expert Opin Pharmacother. 2010 Oct;11(14):2331-50. doi: 10.1517/14656566.2010.498819. Expert Opin Pharmacother. 2010. PMID: 20718589 Review.
[Atrial fibrillation and thromboembolic events prevention. State of the art].
Matteoli S, Trappolini M, Chillotti FM. Matteoli S, et al. Minerva Cardioangiol. 2001 Feb;49(1):1-13. Minerva Cardioangiol. 2001. PMID: 11279381 Review. Italian.